The Center for Medication Safety will consist of two research units.
The Pharmacoepidemiologic and Pharmacoeconomics Research Unit conducts research to identify appropriate use and effects of medications, individually or in combination, particularly in at-risk populations such as seniors and children. This unit also conducts research on the morbidity, mortality and economic costs associated with medications and their potential adverse effects. The unit’s objective is to build a database and profile of those drugs known to trigger adverse reactions. Another objective of the unit will be to design and investigate systems and approaches to reduce ADEs.
The Pharmacogenomics Research Unit conducts research to identify mechanisms of ADEs, particularly in at-risk populations such as seniors and children. The unit’s goal is to develop a better understanding of how and why certain individuals or population groups respond to drugs the way they do. Once we understand the genetic basis of certain drug responses, we will be in a stronger position to predict the safety, toxicity and efficacy of drugs and prevent ADEs.